{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:38:10Z","timestamp":1789659490477,"version":"4.0.1"},"reference-count":25,"publisher":"European Respiratory Society (ERS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2010,11,7]]},"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:p>The proper interval for repeating an interferon-\u03b3 release assay (IGRA) among tuberculosis contacts with initially negative results is unknown. The interval for IGRA conversion after exposure to patients with active pulmonary tuberculosis in an outbreak setting was evaluated.<\/jats:p><jats:p>In a platoon of 32 soldiers, four active pulmonary tuberculosis patients, in addition to one index patient, were diagnosed during a contact investigation. For the other 27 contacts, a tuberculin skin test (TST) and QuantiFERON<jats:sup>\u00ae<\/jats:sup>TB-Gold In-Tube (QFT-GIT) assay were performed. For soldiers with a negative result on the initial QFT-GIT assay, the test was repeated at 2, 4, 8, 14, 18 and 30 weeks until positive conversion occurred. When conversion was identified, the subject was treated for latent tuberculosis infection.<\/jats:p><jats:p>Initially, 17 (63.0%) soldiers gave positive QFT-GIT results, whereas 21 (77.8%) showed positive TST results. Among 10 participants with initially negative QFT-GIT results, three showed conversion at 2 weeks, three at 4 weeks and three at 14 weeks. Conversion did not occur during the 30-week observation period in one contact.<\/jats:p><jats:p>Based on the tuberculosis exposure time-points among the contacts, IGRA conversion generally occurred 4\u20137 weeks after exposure, although it could occur as late as 14\u201322 weeks after exposure.<\/jats:p>","DOI":"10.1183\/09031936.00089510","type":"journal-article","created":{"date-parts":[[2010,12,10]],"date-time":"2010-12-10T02:54:56Z","timestamp":1291949696000},"page":"1447-1452","source":"Crossref","is-referenced-by-count":66,"title":["Time interval to conversion of interferon-\u03b3 release assay after exposure to tuberculosis"],"prefix":"10.1183","volume":"37","author":[{"given":"S.W.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.K.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.Y.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-J.","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2010,12,9]]},"reference":[{"key":"2024102020302124000_37.6.1447.1","unstructured":"World Health Organization. Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009. Report No. WHO\/HTM\/TB\/2009.411. Geneva, World Health Organization, 2009"},{"key":"2024102020302124000_37.6.1447.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00261402"},{"key":"2024102020302124000_37.6.1447.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp021045"},{"key":"2024102020302124000_37.6.1447.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.22.2756"},{"key":"2024102020302124000_37.6.1447.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-5-200703060-00006"},{"key":"2024102020302124000_37.6.1447.6","unstructured":"National Institute for Health and Clinical Excellence. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. Clinical Guideline 33. London, National Institute for Health and Clinical Excellence, 2006"},{"key":"2024102020302124000_37.6.1447.7","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection \u2013 United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2024102020302124000_37.6.1447.8","first-page":"764","article-title":"On the period of incubation in tuberculosis","volume":"96","author":"Wasz-Hockert","year":"1947","journal-title":"Ann Med Intern Fenn"},{"key":"2024102020302124000_37.6.1447.9","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"key":"2024102020302124000_37.6.1447.10","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.6.968"},{"key":"2024102020302124000_37.6.1447.11","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2008.65.4.269"},{"key":"2024102020302124000_37.6.1447.12","first-page":"1342","article-title":"The role of TST in the diagnosis of latent tuberculosis infection among military personnel in South Korea","volume":"10","author":"Choi","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020302124000_37.6.1447.13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1513"},{"key":"2024102020302124000_37.6.1447.14","first-page":"633","article-title":"Combined use of QuantiFERON\u00ae-TB Gold assay and chest computed tomography in a tuberculosis outbreak","volume":"13","author":"Lew","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020302124000_37.6.1447.15","unstructured":"Cellestis, Inc. QuantiFERON\u00ae-TB Gold (In-Tube Method) Package Insert. Valencia, CA, Cellestis, Inc., 2006. www.cellestis.com\/IRM\/Content\/pdf\/QuantiFeron%20US%20VerH_Jul2010.pdf Date last updated: July 2010. Date last accessed: October 7, 2010"},{"key":"2024102020302124000_37.6.1447.16","unstructured":"World Health Organization. Laboratory Services in Tuberculosis Control. Geneva, World Health Organization, 1998"},{"key":"2024102020302124000_37.6.1447.17","unstructured":"World Health Organization. Treatment of Tuberculosis: Guidelines for National Programmes. 3rd Edn. Geneva, World Health Organization, 2003"},{"key":"2024102020302124000_37.6.1447.18","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.11.887"},{"key":"2024102020302124000_37.6.1447.19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/jcm.31.2.406-409.1993","article-title":"Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology","volume":"31","author":"van Embden","year":"1993","journal-title":"J Clin Microbiol"},{"key":"2024102020302124000_37.6.1447.20","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2024102020302124000_37.6.1447.21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00017807"},{"key":"2024102020302124000_37.6.1447.22","first-page":"788","article-title":"Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection","volume":"11","author":"Igari","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020302124000_37.6.1447.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2008.02103.x"},{"key":"2024102020302124000_37.6.1447.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200811-1704OC"},{"key":"2024102020302124000_37.6.1447.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-472OC"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.00089510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:27:38Z","timestamp":1740378458000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.00089510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,9]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,1]]},"published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1183\/09031936.00089510"],"URL":"https:\/\/doi.org\/10.1183\/09031936.00089510","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,9]]}}}